These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29702156)

  • 41. Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas.
    Zhou J; Zhao L; Yang Z; Chen Y; Wu X; Xue W
    BMC Urol; 2022 Jul; 22(1):109. PubMed ID: 35850864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel case of t(X;1)(p11.2;p34) in a renal cell carcinoma with TFE3 rearrangement and favorable outcome in a 57-year-old patient.
    Haudebourg J; Hoch B; Fabas T; Burel-Vandenbos F; Carpentier X; Amiel J; Cardot-Leccia N; Michiels JF; Pedeutour F
    Cancer Genet Cytogenet; 2010 Jul; 200(2):75-8. PubMed ID: 20620589
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TFE3-positive renal cell carcinomas are not always Xp11 translocation carcinomas: Report of a case with a TPM3-ALK translocation.
    Thorner PS; Shago M; Marrano P; Shaikh F; Somers GR
    Pathol Res Pract; 2016 Oct; 212(10):937-942. PubMed ID: 27450657
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions with lymph node metastasis diagnosed after an injury accident: report of a case].
    Chen Y; Kang S; Qiu J
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):123-4. PubMed ID: 24742576
    [No Abstract]   [Full Text] [Related]  

  • 45. Targeting chemoresistance in Xp11.2 translocation renal cell carcinoma using a novel polyamide-chlorambucil conjugate.
    Funasaki S; Mehanna S; Ma W; Nishizawa H; Kamikubo Y; Sugiyama H; Ikeda S; Motoshima T; Hasumi H; Linehan WM; Schmidt LS; Ricketts C; Suda T; Oike Y; Kamba T; Baba M
    Cancer Sci; 2022 Jul; 113(7):2352-2367. PubMed ID: 35396773
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The preliminary experiences of translocation renal cell carcinoma and literature review.
    Su HH; Sung MT; Chiang PH; Cheng YT; Chen YT
    Kaohsiung J Med Sci; 2014 Aug; 30(8):402-8. PubMed ID: 25002378
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dynamic Computed Tomographic Features of Adult Renal Cell Carcinoma Associated With Xp11.2 Translocation/TFE3 Gene Fusions: Comparison With Clear Cell Renal Cell Carcinoma.
    He J; Gan W; Liu S; Zhou K; Zhang G; Guo H; Zhu B
    J Comput Assist Tomogr; 2015; 39(5):730-6. PubMed ID: 25955396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinicopathologic Features of Translocation Renal Cell Carcinoma.
    Ellati RT; Abukhiran I; Alqasem K; Jasser J; Khzouz J; Bisharat T; Al-Saidi I; Al-Daghmin A
    Clin Genitourin Cancer; 2017 Feb; 15(1):112-116. PubMed ID: 27372562
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nuclear translocation of ASPL-TFE3 fusion protein creates favorable metabolism by mediating autophagy in translocation renal cell carcinoma.
    Fang R; Wang X; Xia Q; Zhao M; Zhang H; Wang X; Ye S; Cheng K; Liang Y; Cheng Y; Gu Y; Rao Q
    Oncogene; 2021 May; 40(18):3303-3317. PubMed ID: 33846569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An aggressive course of Xp11 translocation renal cell carcinoma in a 28-year-old man.
    Koie T; Yoneyama T; Hashimoto Y; Kamimura N; Kusumi T; Kijima H; Ohyama C
    Int J Urol; 2009 Mar; 16(3):333-5. PubMed ID: 19298350
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.
    Rao Q; Shen Q; Xia QY; Wang ZY; Liu B; Shi SS; Shi QL; Yin HL; Wu B; Ye SB; Li L; Chen JY; Pan MH; Li Q; Li R; Wang X; Zhang RS; Yu B; Ma HH; Lu ZF; Zhou XJ
    Am J Surg Pathol; 2015 Sep; 39(9):1181-96. PubMed ID: 26274027
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A rare case of TFE-related pigmented renal tumor with overlapping features between melanotic Xp11 translocation renal cancer and Xp11 renal cell carcinoma with melanotic features.
    Cardili L; Wrublevsky Pereira G; Viana CR
    Pathol Int; 2017 Apr; 67(4):208-213. PubMed ID: 28208226
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Altered expression of key cell cycle regulators in renal cell carcinoma associated with Xp11.2 translocation.
    Barroca H; Castedo S; Vieira J; Teixeira M; Müller-Höcker J
    Pathol Res Pract; 2009; 205(7):466-72. PubMed ID: 19246164
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Xp11.2 translocation renal cell carcinoma with SFPQ/PSF-TFE3 fusion gene: A case report with unusual histopathologic findings.
    Ishikawa N; Nagase M; Takami S; Nagano N; Araki A; Iwahashi T; Yamauchi N; Yamasaki T; Shiina H; Maruyama R
    Pathol Res Pract; 2019 Sep; 215(9):152479. PubMed ID: 31153695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kidney carcinoma associated with Xp11.2 translocation / TFE3 (ASPL-TFE3) gene fusion.
    Salles PG; Soto M
    Int Braz J Urol; 2005; 31(3):251-4. PubMed ID: 15992428
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusion: Report of 5 cases and literature review.
    Wang H; Jing H; Cao Z; Liu Q
    Clin Nephrol; 2019 Mar; 91(3):192-194. PubMed ID: 30371348
    [No Abstract]   [Full Text] [Related]  

  • 57. Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma.
    Damayanti NP; Budka JA; Khella HWZ; Ferris MW; Ku SY; Kauffman E; Wood AC; Ahmed K; Chintala VN; Adelaiye-Ogala R; Elbanna M; Orillion A; Chintala S; Kao C; Linehan WM; Yousef GM; Hollenhorst PC; Pili R
    Clin Cancer Res; 2018 Dec; 24(23):5977-5989. PubMed ID: 30061365
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients.
    Agizamhan S; Qu F; Liu N; Sun J; Xu W; Zhang L; Guo H; Gan W
    BMC Urol; 2018 Jun; 18(1):60. PubMed ID: 29890986
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Amog Xp11 Translocation Cancers.
    Pivovarcikova K; Grossmann P; Alaghehbandan R; Sperga M; Michal M; Hes O
    Am J Surg Pathol; 2017 Jan; 41(1):138-140. PubMed ID: 27631518
    [No Abstract]   [Full Text] [Related]  

  • 60. Dynamic Contrast-Enhanced CT Characterization of Xp11.2 Translocation/TFE3 Gene Fusions versus Papillary Renal Cell Carcinomas.
    He J; Zhou K; Zhu B; Zhang G; Li X; Guo H; Gan W; Zhou Z; Liu T
    Biomed Res Int; 2015; 2015():298679. PubMed ID: 26636097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.